The Incubator #471 - [Journal Club] - đź“Ś The remarkable effect of probiotics on NEC in Sweden
Oct 13, 2026
A Swedish national cohort of nearly 4,700 very preterm infants sparks a spirited look at probiotics and neonatal outcomes. The discussion explores dramatic reductions in death, NEC, and surgical NEC, comparisons with Dutch and US research, strain-specific effects, conflicts of interest, and the tricky role of immortal time bias. Training reform, potential CME, and an upcoming neonatal conference also make an appearance.
AI Snips
Chapters
Transcript
Episode notes
Why Probiotic Evidence Varies So Much
- Probiotic effects depend heavily on strain, dose, timing, population, and product quality.
- Sweden’s national experience is compelling, but safety and manufacturing variability complicate bedside adoption elsewhere.
Sweden’s Three-Strain Probiotic Protocol
- Sweden shifted from no probiotic use to national standard care in 2020 for infants born at 28–31 weeks.
- The regimen used one billion CFUs daily of Bifidobacterium infantis, Bifidobacterium lactis, and Streptococcus thermophilus until 34 weeks.
What The Swedish Cohort Actually Included
- The study analyzed 4,695 infants, including 1,571 probiotic-exposed babies, with a mean gestational age of 30 weeks.
- Probiotic recipients differed clinically, including lower gestational age, lower birth-weight Z scores, and less invasive ventilation.